Compare TRBN to:
After Hours: 3.80 0.00 (0.00%) 4:00pm ET
| Last Trade: | 3.80 |
|---|---|
| Trade Time: | Dec 23 |
| Change: | |
| Prev Close: | 3.85 |
| Open: | 3.84 |
| Bid: | 3.18 x 200 |
| Ask: | N/A |
| 1y Target Est: | 10.00 |
| Day's Range: | 3.79 - 3.93 |
|---|---|
| 52wk Range: | 1.10 - 6.75 |
| Volume: | 28,161 |
| Avg Vol (3m): | 24,429.2 |
| Market Cap: | 77.38M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.67 |
| Div & Yield: | N/A (N/A) |
| Thu, Dec 10 | Facet rejects Biogen Idec offerat bizjournals.com |
| Mon, Dec 7 | Trubion and Facet Biotech Announce Presentation of Positive TRU-016 Data at the 2009 ASH Annual MeetingPR Newswire |
| Fri, Dec 4 | Our Final Offer (Maybe)! That's a FACT!at Motley Fool |
| Thu, Dec 3 | UPDATE - Biogen ups offer for Facet Biotech to $17.50/shareat Reuters |
| Mon, Nov 16 | TRUBION PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online |
| Mon, Nov 16 | Trubion shakes up managementat bizjournals.com |
| Mon, Nov 16 | Trubion Pharmaceuticals, Inc. Announces Transition in Company LeadershipPR Newswire |
| Wed, Nov 11 | Trubion Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 ASH Annual MeetingPR Newswire |
| Wed, Nov 11 | TRUBION PHARMACEUTICALS, INC FinancialsEDGAR Online Financials |
| Sun, Nov 8 | New Star Analyst Rankings for Trubion Pharmaceuticals, Inc.StarMine |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.